# Green Thumb Industries Inc.: financial statements, quarterly

GTBIF · OTC · CIK 1795139 · [Consumer staples](/sectors/consumer-staples.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gtbif.md) · [Financials](/companies/gtbif/financials.md) · [Filings](/companies/gtbif/filings.md) · [Insiders](/companies/gtbif/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gtbif/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [275](/filings/0000950170-25-028273.md) | [278](/filings/0000950170-25-028273.md) | [276](/filings/0001193125-26-071672.md) | [280](/filings/0001193125-26-071672.md) | [287](/filings/0001193125-26-071672.md) | [294](/filings/0001193125-26-071672.md) | [280](/filings/0001193125-26-071672.md) | [293](/filings/0001193125-26-071672.md) | [291](/filings/0001193125-26-071672.md) | [311](/filings/0001193125-26-071672.md) | [300](/filings/0001193125-26-209127.md) | [307](/filings/0001193125-26-332841.md) |
| Cost of revenue | $m | [142](/filings/0000950170-24-123669.md) | [136 d](/filings/0001193125-26-071672.md) | [131](/filings/0000950170-25-066295.md) | [130](/filings/0000950170-25-104519.md) | [139](/filings/0001193125-25-266987.md) | [136 d](/filings/0001193125-26-071672.md) | [136](/filings/0001193125-26-209127.md) | [147](/filings/0001193125-26-332841.md) | [147](/filings/0001193125-25-266987.md) | [170 d](/filings/0001193125-26-071672.md) | [157](/filings/0001193125-26-209127.md) | [169](/filings/0001193125-26-332841.md) |
| Gross profit | $m | [134](/filings/0000950170-24-123669.md) | [143 d](/filings/0001193125-26-071672.md) | [145](/filings/0000950170-25-066295.md) | [151](/filings/0000950170-25-104519.md) | [148](/filings/0001193125-25-266987.md) | [158 d](/filings/0001193125-26-071672.md) | [143](/filings/0001193125-26-209127.md) | [146](/filings/0001193125-26-332841.md) | [144](/filings/0001193125-25-266987.md) | [141 d](/filings/0001193125-26-071672.md) | [144](/filings/0001193125-26-209127.md) | [138](/filings/0001193125-26-332841.md) |
| Selling, general and administrative | $m | [84.8](/filings/0000950170-24-123669.md) | [92.3 d](/filings/0001193125-26-071672.md) | [74.3](/filings/0000950170-25-066295.md) | [96.5](/filings/0000950170-25-104519.md) | [105](/filings/0001193125-25-266987.md) | [101 d](/filings/0001193125-26-071672.md) | [101](/filings/0001193125-26-209127.md) | [107](/filings/0001193125-26-332841.md) | [107](/filings/0001193125-25-266987.md) | [122 d](/filings/0001193125-26-071672.md) | [103](/filings/0001193125-26-209127.md) | [118](/filings/0001193125-26-332841.md) |
| Operating income | $m | [49.0](/filings/0000950170-25-028273.md) | [50.3](/filings/0000950170-25-028273.md) | [70.7](/filings/0001193125-26-071672.md) | [54.0](/filings/0001193125-26-071672.md) | [42.6](/filings/0001193125-26-071672.md) | [57.1](/filings/0001193125-26-071672.md) | [42.5](/filings/0001193125-26-209127.md) | [39.4](/filings/0001193125-26-332841.md) | [36.7](/filings/0001193125-26-071672.md) | [19.0](/filings/0001193125-26-071672.md) | [40.7](/filings/0001193125-26-209127.md) | [20.0](/filings/0001193125-26-332841.md) |
| Interest expense | $m | [4.6](/filings/0000950170-23-061475.md) | [7.7 d](/filings/0000950170-24-022653.md) | [7.5](/filings/0000950170-24-056173.md) | [6.0](/filings/0000950170-24-091168.md) | [5.3](/filings/0001193125-25-266987.md) | [5.5 d](/filings/0001193125-26-071672.md) | [4.9](/filings/0001193125-26-209127.md) | [5.0](/filings/0001193125-26-332841.md) | [5.2](/filings/0001193125-25-266987.md) | [4.9 d](/filings/0001193125-26-071672.md) | [5.2](/filings/0001193125-26-209127.md) | [6.1](/filings/0001193125-26-332841.md) |
| Income tax | $m | [34.5](/filings/0000950170-24-123669.md) | [24.7 d](/filings/0001193125-26-071672.md) | [32.1](/filings/0000950170-25-066295.md) | [31.9](/filings/0000950170-25-104519.md) | [30.9](/filings/0001193125-25-266987.md) | [31.3 d](/filings/0001193125-26-071672.md) | [31.3](/filings/0001193125-26-209127.md) | [21.6](/filings/0001193125-26-332841.md) | [49.1](/filings/0001193125-25-266987.md) | [45.3 d](/filings/0001193125-26-071672.md) | [48.1](/filings/0001193125-26-209127.md) | [12.5](/filings/0001193125-26-332841.md) |
| Net income | $m | [10.5](/filings/0000950170-25-028273.md) | [3.2](/filings/0000950170-25-028273.md) | [31.1](/filings/0001193125-26-071672.md) | [20.7](/filings/0001193125-26-071672.md) | [8.6](/filings/0001193125-26-071672.md) | [12.7](/filings/0001193125-26-071672.md) | [8.3](/filings/0001193125-26-209127.md) | [(0.6)](/filings/0001193125-26-332841.md) | [23.3](/filings/0001193125-26-071672.md) | [83.2](/filings/0001193125-26-071672.md) | [15.4](/filings/0001193125-26-209127.md) | [4.9](/filings/0001193125-26-332841.md) |
| Diluted EPS | $ per share | [0.05](/filings/0000950170-25-028273.md) | [0.01](/filings/0000950170-25-028273.md) | [0.13](/filings/0001193125-26-071672.md) | [0.09](/filings/0001193125-26-071672.md) | [0.04](/filings/0001193125-26-071672.md) | [0.04](/filings/0001193125-26-071672.md) | [0.04](/filings/0001193125-26-209127.md) | [(0.01)](/filings/0001193125-26-332841.md) | [0.10](/filings/0001193125-26-071672.md) | [0.22](/filings/0001193125-26-071672.md) | [0.07](/filings/0001193125-26-209127.md) | [0.02](/filings/0001193125-26-332841.md) |
| Basic EPS | $ per share | [0.05](/filings/0000950170-25-028273.md) | [0.01](/filings/0000950170-25-028273.md) | [0.13](/filings/0001193125-26-071672.md) | [0.09](/filings/0001193125-26-071672.md) | [0.04](/filings/0001193125-26-071672.md) | [0.05](/filings/0001193125-26-071672.md) | [0.04](/filings/0001193125-26-209127.md) | [(0.01)](/filings/0001193125-26-332841.md) | [0.10](/filings/0001193125-26-071672.md) | [0.23](/filings/0001193125-26-071672.md) | [0.07](/filings/0001193125-26-209127.md) | [0.02](/filings/0001193125-26-332841.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [162](/filings/0001193125-26-071672.md) | not reported | not reported | [174](/filings/0001193125-25-266987.md) | [172](/filings/0001193125-26-071672.md) | [211](/filings/0001193125-26-209127.md) | not reported | [226](/filings/0001193125-25-266987.md) | [274](/filings/0001193125-26-071672.md) | [345](/filings/0001193125-26-209127.md) | not reported |
| Current assets | $m | [320](/filings/0000950170-23-061475.md) | [343](/filings/0000950170-25-028273.md) | [420](/filings/0000950170-24-056173.md) | [404](/filings/0000950170-24-091168.md) | [392](/filings/0000950170-24-123669.md) | [404](/filings/0001193125-26-071672.md) | [445](/filings/0000950170-25-066295.md) | [405](/filings/0000950170-25-104519.md) | [477](/filings/0001193125-25-266987.md) | [577](/filings/0001193125-26-332841.md) | [674](/filings/0001193125-26-209127.md) | [624](/filings/0001193125-26-332841.md) |
| Total assets | $m | [2,499](/filings/0000950170-23-061475.md) | [2,490](/filings/0000950170-25-028273.md) | [2,555](/filings/0000950170-24-056173.md) | [2,541](/filings/0000950170-24-091168.md) | [2,515](/filings/0000950170-24-123669.md) | [2,537](/filings/0001193125-26-071672.md) | [2,569](/filings/0000950170-25-066295.md) | [2,548](/filings/0000950170-25-104519.md) | [2,639](/filings/0001193125-25-266987.md) | [2,790](/filings/0001193125-26-332841.md) | [2,832](/filings/0001193125-26-209127.md) | [2,815](/filings/0001193125-26-332841.md) |
| Current liabilities | $m | [150](/filings/0000950170-23-061475.md) | [126](/filings/0000950170-25-028273.md) | [175](/filings/0000950170-24-056173.md) | [371](/filings/0000950170-24-091168.md) | [161](/filings/0000950170-24-123669.md) | [165](/filings/0001193125-26-071672.md) | [187](/filings/0000950170-25-066295.md) | [179](/filings/0000950170-25-104519.md) | [242](/filings/0001193125-25-266987.md) | [177](/filings/0001193125-26-332841.md) | [194](/filings/0001193125-26-209127.md) | [219](/filings/0001193125-26-332841.md) |
| Total liabilities | $m | [792](/filings/0000950170-23-061475.md) | [787](/filings/0000950170-25-028273.md) | [808](/filings/0000950170-24-056173.md) | [787](/filings/0000950170-24-091168.md) | [740](/filings/0000950170-24-123669.md) | [748](/filings/0001193125-26-071672.md) | [763](/filings/0000950170-25-066295.md) | [749](/filings/0000950170-25-104519.md) | [804](/filings/0001193125-25-266987.md) | [879](/filings/0001193125-26-332841.md) | [935](/filings/0001193125-26-209127.md) | [955](/filings/0001193125-26-332841.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [258](/filings/0000950170-25-028273.md) | not reported | not reported | not reported | [247](/filings/0001193125-26-071672.md) | not reported | not reported |
| Shareholders' equity | $m | [1,706](/filings/0000950170-23-061475.md) | [1,703](/filings/0000950170-25-028273.md) | [1,747](/filings/0000950170-24-056173.md) | [1,754](/filings/0000950170-24-091168.md) | [1,775](/filings/0000950170-24-123669.md) | [1,789](/filings/0001193125-26-071672.md) | [1,807](/filings/0000950170-25-066295.md) | [1,793](/filings/0000950170-25-104519.md) | [1,828](/filings/0001193125-25-266987.md) | [1,905](/filings/0001193125-26-332841.md) | [1,893](/filings/0001193125-26-209127.md) | [1,859](/filings/0001193125-26-332841.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [60.8 d](/filings/0000950170-24-123669.md) | [71.1 d](/filings/0001193125-26-071672.md) | [84.0](/filings/0000950170-25-066295.md) | [20.2 d](/filings/0000950170-25-104519.md) | [47.7 d](/filings/0001193125-25-266987.md) | [43.3 d](/filings/0001193125-26-071672.md) | [74.2](/filings/0001193125-26-209127.md) | [56.4 d](/filings/0001193125-26-332841.md) | [74.1 d](/filings/0001193125-25-266987.md) | [90.1 d](/filings/0001193125-26-071672.md) | [75.8](/filings/0001193125-26-209127.md) | [29.0 d](/filings/0001193125-26-332841.md) |
| Capital expenditure | $m | [54.2 d](/filings/0000950170-24-123669.md) | [36.4 d](/filings/0001193125-26-071672.md) | [14.7](/filings/0000950170-25-066295.md) | [20.3 d](/filings/0000950170-25-104519.md) | [18.0 d](/filings/0001193125-25-266987.md) | [27.2 d](/filings/0001193125-26-071672.md) | [29.8](/filings/0001193125-26-209127.md) | [19.0 d](/filings/0001193125-26-332841.md) | [17.5 d](/filings/0001193125-25-266987.md) | [14.7 d](/filings/0001193125-26-071672.md) | [18.9](/filings/0001193125-26-209127.md) | [20.2 d](/filings/0001193125-26-332841.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [240](/filings/0000950170-25-028273.md) | [239](/filings/0000950170-25-028273.md) | [241](/filings/0001193125-26-071672.md) | [240](/filings/0001193125-26-071672.md) | [238](/filings/0001193125-26-071672.md) | [239](/filings/0001193125-26-071672.md) | [237](/filings/0001193125-26-209127.md) | [236](/filings/0001193125-26-332841.md) | [234](/filings/0001193125-26-071672.md) | [234](/filings/0001193125-26-071672.md) | [232](/filings/0001193125-26-209127.md) | [223](/filings/0001193125-26-332841.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.